Alzheimer disease (AD) is the most common form of neurodegenerative dementia. Amyloid-
β deposition, neurofibrillary tangle formation, and neuro-inflammation are the major …

We have compared the effect of the commonly used ω-3 fatty acid, docosahexaenoic acid
ethyl ester (DHA-EE), and of its 2-hydroxylated DHA form (DHA-H), on brain lipid …

Cumulative evidence indicates that excessive consumption of calories from saturated fat
contributes to the development of Alzheimer's disease (AD). Here, we assess the triggering …

Aging contributes to physiological decline and vulnerability to disease. In the brain, even
with minimal neuronal loss, aging increases oxidative damage, inflammation, demyelination …

Alzheimer's disease (AD) and cardiovascular disease (CVD) are syndromes of aging that
share analogous lesions and risk factors, involving lipoproteins, oxidative damage and …

Growing evidence suggests that docosahexaenoic acid (DHA) exerts neuroprotective
effects, although the mechanism (s) underlying these beneficial effects are not fully …

In the absence of efficient diagnostic and therapeutic tools, Alzheimer's disease (AD) is a
major public health concern due to longer life expectancy in the Western countries. Although …

A growing body of evidence supports the notion that soluble oligomers of amyloid‐β (Aβ)
peptide interact with the neuronal plasma membrane, leading to cell injury and inducing …

Scope Recent studies have shown that omega‐3 PUFAs enriched phospholipids (n‐3 PUFA‐
PLs) have beneficial effects on memory and cognition. However, most reports only attribute …

Significant research attention has focussed on the identification of nutraceutical agents for
the prevention of cognitive decline as a natural means of cognitive preservation in the …